Ordenar

Buscar

01/06/2026 Body Fluid Cell Differentiation: A Comparison Between CellaVision DI-60 and Manual Microscopy in Pleural and Ascitic Fluids
San-José, P, Aljarilla, A, Jiménez, A, González, N, Hernando-Redondo, J, Nomdedéu-Guinot, JF. Body Fluid Cell Differentiation: A Comparison Between CellaVision DI-60 and Manual Microscopy in Pleural and Ascitic Fluids. International Journal of Laboratory Hematology. 2026; 48DOI:. PMID:. IF:2.300(Q2/5D).
01/06/2026 Minor salivary gland tumours: a 30-year institutional experience
León, X, Vilaró, LL, Szafranska, J, Bagué, S, Maso, A, Valero, C, Holgado, A, Olmo, AP. Minor salivary gland tumours: a 30-year institutional experience. JOURNAL OF LARYNGOLOGY AND OTOLOGY. 2026; 140(6)DOI:10.1017/S0022215126104915. PMID:42093629. IF:0.800(Q3/8D).
30/05/2026 Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study
Povala, G, Bellaver, B, Lussier, FZ, Amaral, L, Bauer-Negrini, G, Ferreira, PCL, Rocha, A, Ruppert, E, Medeiros, MS, Tissot, C, Jagust, WJ, Masdeu, JC, Fortea, J, Tudorascu, DL, Soleimani-Meigooni, DN, Lowe, V, Oh, H, Pascual, B, Gordon, BA, Rosa-Neto, P, Baker, S, Pascoal, TA. Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study. LANCET. 2026; 407(10544)DOI:. PMID:42208563. IF:88.500(Q1/1D).
29/05/2026 Adverse HDL remodelling links type 2 diabetes mellitus to subclinical high-risk coronary plaque burden
Giron, GO, Padró, T, Guala, A, Fernández, R, Garcia-Elias, A, Alcover, S, Ramos-Regalado, L, Otero, S, Borrell-Pagés, M, Oliveró, R, Grieve, SM, Maceira, A, Rodríguez-Palomares, JF, Vilahur, G. Adverse HDL remodelling links type 2 diabetes mellitus to subclinical high-risk coronary plaque burden. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56DOI:. PMID:. IF:3.600(Q1/2D).